QualityStocksNewsBreaks Archives - Page 388 of 1387

WednesdayJun 01, 2022 12:24 pm

QualityStocksNewsBreaks – SRAX Inc. (NASDAQ: SRAX) Scheduled Earnings Conference Call

SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its SaaS (“SaaS”) platform, will host an earnings conference call, during which the company will announce and discuss fourth-quarter and full-year earnings for 2021. The call is scheduled for Monday, June 6, 2022, and will begin at 10:30 a.m. ET. SRAX founder and CEO Christopher Miglino and CFO Michael Malone will facilitate the call and provide operational and financial summaries for fiscal year 2021; the call will also include a live Q&A session. Interested parties can register for the webcast and view…

TuesdayMay 31, 2022 2:31 pm

QualityStocksNewsBreaks – SPYR Inc. (SPYR) Inks Acquisition Agreement, Subsidiary Explores Expanding Portfolio

SPYR (OTCQB: SPYR), dba SPYR Technologies, a technology company, has signed a material definitive agreement to acquire GeoTraq Inc. from NASDAQ-traded JanOne Inc. (NASDAQ: JAN). According to the announcement, GeoTraq develops and manufactures self-contained and ultra-small Mobile Internet of Things (“IoT”) modules that can be used for asset tracking and location-based services, as well as sensor modules for remote monitoring. GeoTraq Mobile IoT modules are small, offer a long battery life, consume low power and provide global LPWAN connectivity. Because the modules work right out of the box, users eliminate the hassle and cost of designing and building a printed circuit…

TuesdayMay 31, 2022 2:12 pm

QualityStocksNewsBreaks – Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0) Announces Completion of Annual Filings

Delic Holdings (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0), a leader in new medicines and treatments for a modern world, has reported that, further to its news release dated May 16, 2022, the company has filed its annual financial statements, management’s discussion and analysis, and related certifications for the year ended Dec. 31, 2021, (collectively, the “annual filings”). Delic expects that the management cease trade order (the “MCTO”), which was issued on May 3, 2022, will be revoked in the coming days. While the MCTO remains in effect, the general investing public will continue to be able to trade Delic’s securities.…

TuesdayMay 31, 2022 1:24 pm

QualityStocksNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Announces Exceptional Test Performance of Solid-State Polymer Battery

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced results of its solid-state polymer battery testing with the Battery Innovation Center (“BIC”) in Indiana. According to the update, BIC’s testing results show the solid-state polymer cell, rated at 300 Ah and 3.7 volts, tested in at 343.28 Ah at 4.2 volts, exceeding expectation and in line with test tolerance from previous EV Grid test results. Test data collected from both BIC and EV Grid demonstrate an impressive outcome and future for solid-state batteries. It is expected that with this technology, when scaled to the vehicle pack level,…

TuesdayMay 31, 2022 12:38 pm

QualityStocksNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Announces Launch of JustCBD Products on Amazon.co.uk

Flora (NASDAQ: FLGC), a leading all-outdoor cultivator, manufacturer and distributor of global cannabis products and brands, today announced that its wholly-owned subsidiary JustCBD will be launching its line of Novel Foods-registered CBD products on Amazon.co.uk. Since its entry into the now £700 million CBD market in October 2021, Amazon U.K. has expanded the initial pilot-only program to include vendors who have demonstrated compliance with U.K. CBD Novel Food regulations. Producers awarded U.K. Novel Food authorization must prove the product is safe for consumption and labeled correctly. “With health and wellness playing an increasingly important role in customers’ lives, we are…

TuesdayMay 31, 2022 11:14 am

QualityStocksNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Completes Major Step in Advancement of CYB003 for the Treatment of Major Depressive Disorder

Cybin (NYSE American: CYBN) (NEO: CYBN), a biopharmaceutical company focused on progressing “Psychedelics to Therapeutics(TM),” today announced the submission of an Investigational New Drug (“IND”) application to the U.S. Food and Drug Administration (“FDA”). According to the update, the IND is for Cybin’s phase 1/2a first-in-human clinical trial evaluating CYB003, a proprietary deuterated psilocybin analog, for the treatment of major depressive disorder (“MDD”). “Following the successful completion of our IND-enabling work just last month, we are very excited to have reached this major milestone toward advancing CYB003 into clinical development so quickly. Based on preclinical studies, our proprietary psilocybin analog…

TuesdayMay 31, 2022 11:05 am

QualityStocksNewsBreaks – Playgon Games Inc. (TSX.V: DEAL) (OTCQB: PLGNF) (FSE: 7CR) Releases Q1 2022 Financial Report

Playgon Games (TSX.V: DEAL) (OTCQB: PLGNF) (FSE: 7CR), a propriety SaaS technology company delivering mobile-first live-dealer technology to online gaming operators globally, is reporting its first quarter 2022 financial numbers; the report is for the quarter ended March 31, 2022. Highlights of the report include company revenues of $140,877, which came from Playgon’s Live Dealer platform. The company noted that it saw increased player betting throughout the quarter, a strong indicator for future revenue growth. In addition, Playgon observed an increase in player win percentage resulting in reduced house margins. The company also reported loss for the quarter of $3,899,555,…

TuesdayMay 31, 2022 10:48 am

QualityStocksNewsBreaks – Eat Well Investment Group Inc. (CSE: EWG) (OTC: EWGFF) Shares Update on Filing of Audit, 2021 Financials

Eat Well Group (CSE: EWG) (OTC: EWGFF), a publicly traded investment company, has released an update regarding the anticipated timelines for the filing of its audited annual financial statements for the year ended Nov. 30, 2021, as well as other required documents, including the related management’s discussion and analysis and certificates of its CEO and CFO. The announcement noted that additional delays have taken place, although the company and its auditors continue to work diligently to file the required documents as soon as possible. According to the most recent estimates, the company plans on filing the information by June 10,…

FridayMay 27, 2022 3:03 pm

QualityStocksNewsBreaks – Golden Matrix Group Inc. (NASDAQ: GMGI) Eyeing Expansion, Scaling

Golden Matrix (NASDAQ: GMGI), a developer and licensor of online gaming platforms, systems and gaming content, has historically focused on business-to-business (“B2B”) operations, providing gaming companies with the tools they need to improve profits and reduce churn, industry nomenclature for losing players. “Golden Matrix IP includes its flagship GM-X System and its recently released next-gen GM-Ag System that is regarded as the industry benchmark, delivering access to 10,000+ games from more than 25 providers,” a recent article reads. “Most of Golden Matrix’s business comes from the Asia Pacific, but management is looking to expand closer to home. In March, the…

FridayMay 27, 2022 2:53 pm

QualityStocksNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Leveraging DehydraTECH(TM) as It Looks to Tap into Various Markets

Lexaria Bioscience Corp. (NASDAQ: LEXX) has been pushing the boundaries of drug delivery through its patented DehydraTECH(TM) technology, which has evidenced more efficient delivery of active pharmaceutical ingredients (“APIs”) into the bloodstream while also increasing their bioavailability. “Its technology has seen application in pharmaceuticals, nutraceuticals, consumer packaged goods, and over-the-counter capsules, pills, tablets, and oral suspensions. Lexaria has explored its usage in the delivery of cannabinoids, nicotine, antivirals, PDE5 inhibitors, and more,” a recent article reads. “All of Lexaria’s efforts serve to demonstrate the superior performance of both its research program and its DehydraTECH drug delivery technology. By doing so,…

Site Search

Company Search

Category: QualityStocksNewsBreaks